Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Reis

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Trials|June 6, 2025
The Research Visit of the Future: an academic-industry model for telehealth, electronic clinical outcomes assessments, and Decentralized Clinical Trials (DCTs)Noah Goodson, Christopher Wiltrout, Joss Warren, et al.
Vascular Medicine (London, England)|October 17, 2024
Changes in the reactive hyperemia index after continuous and interval exerciseDaniel K Sweet, P Daniel Patterson, Steven Reis, et al.
Journal of Clinical Lipidology|September 15, 2024
Long term association of low-density lipoprotein subtypes with coronary artery calcium score and atherosclerotic cardiovascular disease events: Insights from the HeartSCORE studyAlaa Sayed, Justin Swanson, Kevin Kip, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2014
Risk of cardiovascular events in survivors of severe sepsisSachin Yende, Walter Linde-Zwirble, Florian Mayr, et al.
JACC. Case Reports|July 28, 2021
Colchicine Toxicity: The Fatal MasqueraderVinaya Mulkareddy, Carly Sokach, Eric Bucklew, et al.
Annals of Internal Medicine|June 16, 2025
Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation StudiesAnum Saeed, Suresh R Mulukutla, Floyd Thoma, et al.
Atherosclerosis Plus|November 3, 2025
Midlife ICAM-1 levels may predict cardiovascular disease and cognitive decline in latelife: Insights from the HeartSCORE studyKhaled Abdoun, Justin Swanson, Ian Pollack, et al.
European Journal of Clinical Nutrition|November 9, 2020
Phytoestrogen blood levels and adverse outcomes in women with suspected ischemic heart diseaseLili Barsky, Galen Cook-Wiens, Mark Doyle, et al.
Obesity (Silver Spring, Md.)|February 7, 2012
Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trialInga Peter, Jeanne M McCaffery, Alyson Kelley-Hedgepeth, et al.
Ethnicity & Disease|April 10, 2020
Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility StudyAmber Johnson, Stephen Broughton, Lisa Aponte-Soto, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Trials|June 6, 2025
The Research Visit of the Future: an academic-industry model for telehealth, electronic clinical outcomes assessments, and Decentralized Clinical Trials (DCTs)Noah Goodson, Christopher Wiltrout, Joss Warren, et al.
Vascular Medicine (London, England)|October 17, 2024
Changes in the reactive hyperemia index after continuous and interval exerciseDaniel K Sweet, P Daniel Patterson, Steven Reis, et al.
Journal of Clinical Lipidology|September 15, 2024
Long term association of low-density lipoprotein subtypes with coronary artery calcium score and atherosclerotic cardiovascular disease events: Insights from the HeartSCORE studyAlaa Sayed, Justin Swanson, Kevin Kip, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2014
Risk of cardiovascular events in survivors of severe sepsisSachin Yende, Walter Linde-Zwirble, Florian Mayr, et al.
JACC. Case Reports|July 28, 2021
Colchicine Toxicity: The Fatal MasqueraderVinaya Mulkareddy, Carly Sokach, Eric Bucklew, et al.
Annals of Internal Medicine|June 16, 2025
Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation StudiesAnum Saeed, Suresh R Mulukutla, Floyd Thoma, et al.
Atherosclerosis Plus|November 3, 2025
Midlife ICAM-1 levels may predict cardiovascular disease and cognitive decline in latelife: Insights from the HeartSCORE studyKhaled Abdoun, Justin Swanson, Ian Pollack, et al.
European Journal of Clinical Nutrition|November 9, 2020
Phytoestrogen blood levels and adverse outcomes in women with suspected ischemic heart diseaseLili Barsky, Galen Cook-Wiens, Mark Doyle, et al.
Obesity (Silver Spring, Md.)|February 7, 2012
Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trialInga Peter, Jeanne M McCaffery, Alyson Kelley-Hedgepeth, et al.
Ethnicity & Disease|April 10, 2020
Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility StudyAmber Johnson, Stephen Broughton, Lisa Aponte-Soto, et al.
Pageof 3